Boji Medical Technology Co.,Ltd. (SHE:300404)

China · Delayed Price · Currency is CNY

13.40

-0.19 (-1.40%)

Oct 13, 2026, 4:00 PM EDT

Market Cap	5.13B +34.2%
Revenue (ttm)	961.34M +26.1%
Net Income	52.12M +266.8%
EPS	0.14 +265.8%
Shares Out	383.08M
PE Ratio	98.70
Forward PE	n/a
Dividend	0.01 (0.10%)
Ex-Dividend Date	Jun 17, 2026

Volume	29,117,737
Open	13.31
Previous Close	13.59
Day's Range	12.50 - 13.53
52-Week Range	8.15 - 17.99
Beta	0.33
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 28, 2026

About Boji Medical Technology

Boji Medical Technology Co.,Ltd. provides professional contract research services for research and development, and production of drugs and medical devices to pharmaceutical enterprises in China and internationally. The company offers pre-clinical research, clinical research, and other consulting services. It also provides clinical drug production, pilot test scale-up, process verification batch production, and drug registration and approval services. In addition, it engages in the screening, evaluation, verification, and trading of technologic... [Read more]

Industry Biotechnology

Sector Healthcare

Founded 1998

Employees 1,198

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 300404

Full Company Profile

Financial Performance

In 2025, Boji Medical Technology's revenue was 868.64 million, an increase of 17.06% compared to the previous year's 742.02 million. Earnings were 30.49 million, an increase of 5.97%.

Financial Statements